Arcturus Therapeutics Holdings Inc.
ARCT · NASDAQ
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Arcturus Therapeutics Holdings Inc. (ARCT) is an American biotechnology company specializing in the development and research of messenger RNA (mRNA)-based therapeutics. With innovative approaches to treating diseases, including infectious diseases and genetic disorders, Arcturus Therapeutics Holdings Inc. is a key player in the field of biotechnology. The company focuses on harnessing mRNA for the development of novel therapeutic solutions. Arcturus Therapeutics Holdings Inc. (ARCT) shares could be suitable for investors looking to invest in the biotechnology sector with innovative and promising therapeutic approaches.
Sector
Healthcare
Industry
Biotechnology
CEO
Joseph E. Payne
Employees
109
Headquarters
San Diego
Upcoming events
Earnings
Upcoming earnings report